Skip to content

OMNI BIO PHARMACEUTICAL, INC.: filings

Every OMNI BIO PHARMACEUTICAL, INC. annual and quarterly report in the SEC record with the published financial measures it tagged, 15 filings, each linked to its SEC index.

Filing record ends 2015-02-17

The latest filing in this captured record is a 10-Q filed 2015-02-17. No later filing is in the SEC companyfacts record captured on 2026-09-23. OMNI BIO PHARMACEUTICAL, INC. may have stopped filing, merged, or changed its reporting entity; nothing on this page describes its current status. Values are as reported at the time.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2015-02-17fiscal Q3 201522570001437749-15-002851
10-Q2014-11-14fiscal Q2 201523610001437749-14-020713
10-Q2014-08-13fiscal Q1 201521440001437749-14-015302
10-K2014-06-16fiscal FY 201429820001437749-14-011253
10-Q2014-02-14fiscal Q3 201325770001437749-14-002142
10-Q2013-11-14fiscal Q2 201325770001437749-13-014726
10-Q2013-08-14fiscal Q1 201325630001437749-13-010718
10-K2013-06-28fiscal FY 201227770001437749-13-008162
10-Q2013-02-14fiscal Q3 201220460001437749-13-001509
10-Q2012-11-14fiscal Q2 201226800001437749-12-011628
10-Q2012-08-14fiscal Q1 201226650001437749-12-008360
10-K2012-07-12fiscal FY 201124690001437749-12-006846
10-Q2012-02-09fiscal Q3 201124750001193125-12-048039
10-Q2011-11-09fiscal Q2 201124740000950123-11-096780
10-Q/A2011-09-14fiscal Q1 201124570000950123-11-084358

Inspect the source

Entity
OMNI BIO PHARMACEUTICAL, INC. / CIK 0001389870
Captured
SEC response SHA-256
b9b3aba6d21aa6d13f2cc53a72b3619a8dce8e5c14df68ddd1351a61e50303b7

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001389870.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))